Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Inventory (2018 - 2025)

Historic Change in Inventory for Sunshine Biopharma (SBFM) over the last 8 years, with Q3 2025 value amounting to $1.3 million.

  • Sunshine Biopharma's Change in Inventory rose 266.09% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year decrease of 2116.21%. This contributed to the annual value of $6.0 million for FY2024, which is 15393.11% up from last year.
  • As of Q3 2025, Sunshine Biopharma's Change in Inventory stood at $1.3 million, which was up 266.09% from $555075.0 recorded in Q2 2025.
  • Sunshine Biopharma's 5-year Change in Inventory high stood at $2.1 million for Q1 2024, and its period low was -$206974.0 during Q4 2022.
  • For the 5-year period, Sunshine Biopharma's Change in Inventory averaged around $569546.4, with its median value being $417318.0 (2023).
  • Within the past 5 years, the most significant YoY rise in Sunshine Biopharma's Change in Inventory was 245676.7% (2022), while the steepest drop was 70271.99% (2022).
  • Sunshine Biopharma's Change in Inventory (Quarter) stood at $34340.0 in 2021, then plummeted by 702.72% to -$206974.0 in 2022, then skyrocketed by 652.94% to $1.1 million in 2023, then skyrocketed by 57.71% to $1.8 million in 2024, then fell by 28.74% to $1.3 million in 2025.
  • Its Change in Inventory was $1.3 million in Q3 2025, compared to $555075.0 in Q2 2025 and $568834.0 in Q1 2025.